Get in Touch
  • Welcome to SynInnova Laboratories Inc.!

    SynInnova is a reputed CRO, established over a decade ago at NINT building in the University of Alberta campus. We are always striving to improve our service and bringing innovative research chemicals on regular basis to support and accelerate your research efforts.

  • Over 20,000 Innovative Research Chemicals

    We have an extensive catalog of over 20,000 innovative research chemicals such as building blocks, scaffolds, reference standards, bioactive analogs, metabolites, impurities to fulfill of your research needs.

  • New Product Suggestions

    If you do not find your required compound in our catalogue or not commercially available, please contact us - we will assist you in making your desired compound. We charge only once we synthesize and deliver to your satisfaction.

  • Chemical Synthesis and Medicinal Chemistry Support

    In partnership with SynInnova we could assist you in designing and synthesizing additional analogs of your specific proprietary scaffold with the help of our in-house medicinal chemist.

  • Rapid Custom Synthesis Support

    Provide diverse early and advanced chemical building blocks, FDA approved drugs and/or candidates under clinical trials as reference compounds to speed up discovery in all disciplines of research and therapeutic areas. Proven track record of reliability, high quality, competitive price and on-time delivery.

Who We Are

SynInnova is a reputed Canadian contract research organization (CRO). After operating for over 10 years from the facility of the University of Alberta campus, we have finally decided to build our own research facility in the City of Edmonton, Canada to better serve the scientific community. Over the years, SynInnova has been reliable and valuable partner and has been supplying many "hard-to-make" custom research chemicals in a timely manner and at competitive prices to support life science research in various therapeutic areas. Even more exciting news is SynInnova has taken a bold step in setting up a state-of-the-art research facility in the chemical hub of Hyderabad, India. Operations are starting from August 01, 2023, employing over 40 research chemists with easy access to analytical facilities, chiral synthesis, and separation. Along with our existing core business model that is making and supplying intermediates and/or final products as life science research chemicals, SynInnova is now getting ready to take challenges not only in custom research chemicals in gram quantities, but also in ever demanding library synthesis of drug-like molecules, scale up of key intermediates and process research chemistry.

What We Do

We support scientific research worldwide by preparing and supplying robust and unique research chemicals to fulfill your research needs. Furthermore, we support your life science research in major therapeutic areas like oncology, virology, anti-infective, diabetes, autoimmune diseases, inflammation and pain, alzheimer and so on by supplying early, mid-stage and advanced key chemical intermediates. The biological targets are of diverse in nature like inhibitors, agonists, antagonists, modulators and blockers. We could synthesize FDA approved drugs and drugs under clinical trials as reference compounds and stable labelled isotopic compounds. We could also assist you in making large number of analogs based on your proprietary designed scaffold in a specific therapeutic area. We also offer both compound based custom synthesis projects and FTE based medicinal chemistry services at a competitive rate with strict confidentiality and exceptional quality.

Our in-depth knowledge in life science research will support your research program by synthesizing and supplying robust key building blocks for a specific biological target in major therapeutic areas. Furthermore, we have the ability to assist your in-house research effort by providing medicinal chemistry support, if required, which is an added benefit to expedite your research program and to achieve your goal in a short time frame.

Our R&D Laboratory Facilities

  • State-of-the art laboratory facilities
  • 600MHz NMR Varian
  • Agilent Technologies 1260 Infinity ELSD (Evaporative Light Scattering Detector)
  • Agilent 1100 Series for HPLC
  • Agilent 1100 Series LC/MS SM model for Mass spec
  • Jasco-J-810 Spectropolarimeter

Research Areas

Cancer

Cardiovascular System

Endocrinology

Immunology

Infection

Neuroscience

Pain & Inflammation

Respiratory System

Our Services



Contract
Research

view

Rapid Custom
Synthesis

view

Stable
Isotopes

view

Medicinal
Chemistry

view

Process
Development

view

Manufacturing

view

Our Competitive Advantages are

  • Easy to collaborate
  • Reproducible results
  • Prompt product delivery
  • Competitive rates
  • Faster adoption and scaling
  • State of the art facilities
  • Located in North America and India
  • Long-lasting relationships

Our Track Record

Since 2008 we have collaborated and delivered a number of commercially inaccessible research chemicals to the multinational companies like Pfizer, Merck, Gilead, Sanofi-Aventis, Bayer, Novartis, abbivie, Sigma-Aldrich, Alfa-Aesar (Thermo-Fisher) and worked with over 500 research labs worldwide. Institutes like NIH, NRC, Broad Institute, Kings College London, Stanford University and UCLA are to name a few. Robust building blocks, drug impurities, chiral intermediates, drug metabolites and labelled compounds - whatever is required SynInnova is willing to take challenges. Completing projects on time at competitive price and scalable to gram quantity is our strength.

Some of Our Clients

Newsletter

To receive the information that is relevant to your work, subscribe to our Newsletter.


Note : To subscribe, please use the email address from your company or academic institution. Non-institutional and personal email addresses are not accepted.